World J Mens Health.  2019 Jan;37(1):12-18. 10.5534/wjmh.180017.

Obstructive Sleep Apnea and Testosterone Deficiency

• Kim SD
• Cho KS

• KMID: 2429718
• DOI: http://doi.org/10.5534/wjmh.180017

Abstract

Obstructive sleep apnea (OSA) is a common disorder characterized by intermittent hypoxia and sleep fragmentation. OSA in middle-aged men is often associated with decreased testosterone secretion, together with obesity and aging. Although OSA treatment does not reliably increase testosterone levels in most studies, OSA treatment with testosterone replacement therapy (TRT) may not only improve hypogonadism, but can also alleviate erectile/sexual dysfunction. However, because TRT may exacerbate OSA in some patients, patients should be asked about OSA symptoms before and after starting TRT. Furthermore, TRT should probably be avoided in patients with severe untreated OSA.

Keyword

Continuous positive airway pressure; Erectile dysfunction; Sexual dysfunction, physiological; Sleep apnea, obstructive; Testosterone

MeSH Terms

Aging
Anoxia
Continuous Positive Airway Pressure
Erectile Dysfunction
Humans
Hypogonadism
Male
Multiple Endocrine Neoplasia Type 1
Obesity
Sexual Dysfunction, Physiological
Sleep Apnea, Obstructive*
Sleep Deprivation
Testosterone*
Testosterone

Figure

• 

  Fig. 1 Potential mechanisms linking obstructive sleep apnea (OSA) and obesity to low testosterone. A bidirectional relationship between testosterone and obesity or OSA is shown. While OSA and obesity lead to lower testosterone, low testosterone promotes obesity and affects sleep quality. REM: rapid eye movement, SHBG: sex hormone binding globulin, GnRH: Gonadotropin-releasing hormone, LH: luteinizing hormone.

• 

  Fig. 2 The plausible mechanisms by which testosterone replacement therapy (TRT) worsens obstructive sleep apnea (OSA). TRT aggravates OSA by several physiologic mechanisms including neuromuscular changes to the airways, changes in metabolic requirements, and changes in the physiologic response to hypoxia and hypercapnia.

Reference

1. Park CY, Hong JH, Lee JH, Lee KE, Cho HS, Lim SJ, et al. Clinical effect of surgical correction for nasal pathology on the treatment of obstructive sleep apnea syndrome. PLoS One. 2014; 9:e98765. PMID: 24896824.

2. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000; 283:1829–1836. PMID: 10770144.

3. Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010; 122:352–360. PMID: 20625114.

4. Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O'Connor GT, Resnick HE, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010; 182:269–277. PMID: 20339144.

5. Teloken PE, Smith EB, Lodowsky C, Freedom T, Mulhall JP. Defining association between sleep apnea syndrome and erectile dysfunction. Urology. 2006; 67:1033–1037. PMID: 16698364.

6. Wittert G. The relationship between sleep disorders and testosterone. Curr Opin Endocrinol Diabetes Obes. 2014; 21:239–243. PMID: 24739309.

7. Bercea RM, Mihaescu T, Cojocaru C, Bjorvatn B. Fatigue and serum testosterone in obstructive sleep apnea patients. Clin Respir J. 2015; 9:342–349. PMID: 24725752.

8. Viana A Jr, Daflon AC, Couto A, Neves D, de Araujo-Melo MH, Capasso R. Nocturnal hypoxemia is associated with low testosterone levels in overweight males and older men with normal weight. J Clin Sleep Med. 2017; 13:1395–1401. PMID: 29065959.

9. Li Z, Tang T, Wu W, Gu L, Du J, Zhao T, et al. Efficacy of nasal continuous positive airway pressure on patients with OSA with erectile dysfunction and low sex hormone levels. Respir Med. 2016; 119:130–134. PMID: 27692134.

10. McLaughlin Crabtree V, Williams NA. Normal sleep in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2009; 18:799–811. PMID: 19836688.

11. Markov D, Goldman M. Normal sleep and circadian rhythms: neurobiologic mechanisms underlying sleep and wakefulness. Psychiatr Clin North Am. 2006; 29:841–853. PMID: 17118271.

12. Dorffner G, Vitr M, Anderer P. The effects of aging on sleep architecture in healthy subjects. Adv Exp Med Biol. 2015; 821:93–100. PMID: 25416113.

13. Li J, Vitiello MV, Gooneratne NS. Sleep in normal aging. Sleep Med Clin. 2018; 13:1–11. PMID: 29412976.

14. Miyatake A, Morimoto Y, Oishi T, Hanasaki N, Sugita Y, Iijima S, et al. Circadian rhythm of serum testosterone and its relation to sleep: comparison with the variation in serum luteinizing hormone, prolactin, and cortisol in normal men. J Clin Endocrinol Metab. 1980; 51:1365–1371. PMID: 7440701.

15. Luboshitzky R, Aviv A, Hefetz A, Herer P, Shen-Orr Z, Lavie L, et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab. 2002; 87:3394–3398. PMID: 12107256.

16. Luboshitzky R, Herer P, Levi M, Shen-Orr Z, Lavie P. Relationship between rapid eye movement sleep and testosterone secretion in normal men. J Androl. 1999; 20:731–737. PMID: 10591612.

17. Luboshitzky R, Zabari Z, Shen-Orr Z, Herer P, Lavie P. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab. 2001; 86:1134–1139. PMID: 11238497.

18. Axelsson J, Ingre M, Akerstedt T, Holmbäck U. Effects of acutely displaced sleep on testosterone. J Clin Endocrinol Metab. 2005; 90:4530–4535. PMID: 15914523.

19. Luboshitzky R, Shen-Orr Z, Herer P. Middle-aged men secrete less testosterone at night than young healthy men. J Clin Endocrinol Metab. 2003; 88:3160–3166. PMID: 12843160.

20. Penev PD. Association between sleep and morning testosterone levels in older men. Sleep. 2007; 30:427–432. PMID: 17520786.

21. Soukhova-O'Hare GK, Shah ZA, Lei Z, Nozdrachev AD, Rao CV, Gozal D. Erectile dysfunction in a murine model of sleep apnea. Am J Respir Crit Care Med. 2008; 178:644–650. PMID: 18535258.

22. Molina FD, Suman M, Carvalho TB, Piatto VB, Taboga SR, Maniglia JV, et al. Evaluation of testosterone serum levels in patients with obstructive sleep apnea syndrome. Braz J Otorhinolaryngol. 2011; 77:88–95. PMID: 21340195.

23. Ruehland WR, Rochford PD, O'Donoghue FJ, Pierce RJ, Singh P, Thornton AT. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep. 2009; 32:150–157. PMID: 19238801.

24. Gambineri A, Pelusi C, Pasquali R. Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. J Endocrinol Invest. 2003; 26:493–498. PMID: 12952360.

25. Luboshitzky R, Lavie L, Shen-Orr Z, Herer P. Altered luteinizing hormone and testosterone secretion in middle-aged obese men with obstructive sleep apnea. Obes Res. 2005; 13:780–786. PMID: 15897488.

26. Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004; 89:5920–5926. PMID: 15579737.

27. Canguven O, Salepci B, Albayrak S, Selimoglu A, Balaban M, Bulbul M. Is there a correlation between testosterone levels and the severity of the disease in male patients with obstructive sleep apnea? Arch Ital Urol Androl. 2010; 82:143–147. PMID: 21341549.

28. Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, et al. Aromatase--a brief overview. Annu Rev Physiol. 2002; 64:93–127. PMID: 11826265.

29. Pasquali R, Casimirri F, Cantobelli S, Melchionda N, Morselli Labate AM, Fabbri R, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism. 1991; 40:101–104. PMID: 1984562.

30. Gambineri A, Pasquali R. Testosterone therapy in men: clinical and pharmacological perspectives. J Endocrinol Invest. 2000; 23:196–214. PMID: 10803480.

31. Kelly DM, Jones TH. Testosterone and obesity. Obes Rev. 2015; 16:581–606. PMID: 25982085.

32. Barrett-Connor E, Dam TT, Stone K, Harrison SL, Redline S, Orwoll E. The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. J Clin Endocrinol Metab. 2008; 93:2602–2609. PMID: 18413429.

33. Paul KN, Laposky AD, Turek FW. Reproductive hormone replacement alters sleep in mice. Neurosci Lett. 2009; 463:239–243. PMID: 19647784.

34. Santamaria JD, Prior JC, Fleetham JA. Reversible reproductive dysfunction in men with obstructive sleep apnoea. Clin Endocrinol (Oxf). 1988; 28:461–470. PMID: 3145819.

35. Grunstein RR, Handelsman DJ, Lawrence SJ, Blackwell C, Caterson ID, Sullivan CE. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab. 1989; 68:352–358. PMID: 2493027.

36. Macrea MM, Martin TJ, Zagrean L. Infertility and obstructive sleep apnea: the effect of continuous positive airway pressure therapy on serum prolactin levels. Sleep Breath. 2010; 14:253–257. PMID: 20563862.

37. Hoekema A, Stel AL, Stegenga B, van der Hoeven JH, Wijkstra PJ, van Driel MF, et al. Sexual function and obstructive sleep apnea-hypopnea: a randomized clinical trial evaluating the effects of oral-appliance and continuous positive airway pressure therapy. J Sex Med. 2007; 4:1153–1162. PMID: 17081222.

38. Meston N, Davies RJ, Mullins R, Jenkinson C, Wass JA, Stradling JR. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med. 2003; 254:447–454. PMID: 14535966.

39. Bratel T, Wennlund A, Carlström K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med. 1999; 93:1–7. PMID: 10464840.

40. Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab. 2011; 96:2341–2353. PMID: 21646372.

41. Hanafy HM. Testosterone therapy and obstructive sleep apnea: is there a real connection. J Sex Med. 2007; 4:1241–1246. PMID: 17645445.

42. Cistulli PA, Grunstein RR, Sullivan CE. Effect of testosterone administration on upper airway collapsibility during sleep. Am J Respir Crit Care Med. 1994; 149:530–532. PMID: 8306057.

43. Schneider BK, Pickett CK, Zwillich CW, Weil JV, McDermott MT, Santen RJ, et al. Influence of testosterone on breathing during sleep. J Appl Physiol (1985). 1986; 61:618–623. PMID: 3745052.

44. Matsumoto AM, Sandblom RE, Schoene RB, Lee KA, Giblin EC, Pierson DJ, et al. Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep. Clin Endocrinol (Oxf). 1985; 22:713–721. PMID: 4017261.

45. Hajjar RR, Kaiser FE, Morley JE. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab. 1997; 82:3793–3796. PMID: 9360543.

46. Hoyos CM, Killick R, Yee BJ, Grunstein RR, Liu PY. Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial. Clin Endocrinol (Oxf). 2012; 77:599–607. PMID: 22512435.

47. Killick R, Wang D, Hoyos CM, Yee BJ, Grunstein RR, Liu PY. The effects of testosterone on ventilatory responses in men with obstructive sleep apnea: a randomised, placebo-controlled trial. J Sleep Res. 2013; 22:331–336. PMID: 23331844.

48. Ylmaz M, Bayazit YA, Ciftci TU, Erdal ME, Urhan M, Kokturk O, et al. Association of serotonin transporter gene polymorphism with obstructive sleep apnea syndrome. Laryngoscope. 2005; 115:832–836. PMID: 15867649.

49. Tatsumi K, Hannhart B, Pickett CK, Weil JV, Moore LG. Effects of testosterone on hypoxic ventilatory and carotid body neural responsiveness. Am J Respir Crit Care Med. 1994; 149:1248–1253. PMID: 8173766.

50. Liu PY, Yee B, Wishart SM, Jimenez M, Jung DG, Grunstein RR, et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab. 2003; 88:3605–3613. PMID: 12915643.

51. Choi JB, Loredo JS, Norman D, Mills PJ, Ancoli-Israel S, Ziegler MG, et al. Does obstructive sleep apnea increase hematocrit? Sleep Breath. 2006; 10:155–160. PMID: 16770648.

52. Bachman E, Travison TG, Basaria S, Davda MN, Guo W, Li M, et al. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci. 2014; 69:725–735. PMID: 24158761.

53. Margel D, Cohen M, Livne PM, Pillar G. Severe, but not mild, obstructive sleep apnea syndrome is associated with erectile dysfunction. Urology. 2004; 63:545–549. PMID: 15028455.

54. Liu L, Kang R, Zhao S, Zhang T, Zhu W, Li E, et al. Sexual dysfunction in patients with obstructive sleep apnea: a systematic review and meta-analysis. J Sex Med. 2015; 12:1992–2003. PMID: 26395783.

55. Gonçalves MA, Guilleminault C, Ramos E, Palha A, Paiva T. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med. 2005; 6:333–339. PMID: 15946896.